SFA
BIO icon

Sequoia Financial Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sequoia Financial Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-750
Closed -$209K – 2180
2026
Q1 		$209K Buy
+750
New +$216K ﹤0.01% 1771
2024
Q1 		– Sell
-831
Closed -$268K – 1180
2023
Q4 		$268K Buy
+831
New +$260K ﹤0.01% 973
2023
Q3 		– Sell
-856
Closed -$325K – 970
2023
Q2 		$325K Buy
+856
New +$348K 0.01% 663

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sequoia Financial Advisors's BIO Position: Q2 2026 in Review

Sequoia Financial Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 750 shares — an estimated $209K sold.

Sequoia Financial Advisors first reported a position in BIO in Q2 2023 and held it in 3 quarters. The position peaked at $325K in Q2 2023. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Sequoia Financial Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Sequoia Financial Advisors sold 750 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $209K.
  • Sequoia Financial Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and held it in 3 quarters.
  • Sequoia Financial Advisors's Bio-Rad Laboratories Class A position peaked at $325K in Q2 2023.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.